How are the interests of incapacitated research participants protected through legislation? An Italian study on legal agency for dementia patients

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Gainotti, Sabina ^a   Imperatori, Susanna Fusari ^b   Spila Alegiani, Stefania ^a   Maggiore, Laura ^b   Galeotti, Francesca ^a   Vanacore, Nicola ^a   Petrini, Carlo ^a   Raschetti, Roberto ^a   Mariani, Claudio ^b   Clerici, Francesca ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL RESEARCH; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HUMAN; INFORMED CONSENT; ITALY; LEGAL ASPECT; LEGAL COMPETENCE; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PATIENT PARTICIPATION; RESEARCH ETHICS; RESEARCH SUBJECT; HUMAN EXPERIMENT;

DEMENTIA; HUMAN EXPERIMENTATION; HUMANS; ITALY;

EID: 77955287727     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011150     Document Type: Article

References (43)

1. Nuremberg Military Tribunals. The Nuremberg Code. Trial of war criminals before the Nuremberg Military Tribunals under Control Council Law n. 10. Nuremberg, October 1946-April 1949. Washington, DC: Government Printing Office; 1949-1953, Volume 2: 181-182.
2. World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Current version Seoul, October 2008. Available: www.wma.net/e/policy/b3.htm Accessed 2010 March 3.
3. Applebaum PS (2007) Assessment of patient's competence to consent to treatment. New Engl J Med 357: 1834-1840.
4. Stocking CB, Hougham GW, Baron AR, Sachs GA (2003) Are the rules for research with subjects with dementia changing? Neurology 61: 1649-1651.
5. Warner J, Nomani E (2008) Giving consent in dementia research. Lancet 372: 183-185.
6. European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products of human use. Official Journal of the European Communities.2001 May 1. L121: 34-44.
7. European Forum for Good Clinical Practice. EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in the European Union 2006 November. Available: http://www.efgcp.be/html.asp?what=efgcpreport.htm&L1=5&L2=1 Accessed 2010 March 3.
8. Belgium. Loi relative aux Expérimentations sur la Personne Humaine.Moniteur Belge 2004 May 7.
9. Denmark. Act on a Biomedical research Ethics Committee System and the Processing of Biomedical research Projects 2003 May 28.
10. Finland. Ministry of Social Affairs and Health. Medical Research Act. No. 488/1999.
11. France. Code de la santé publique. Première partie: Protection générale de la santé. Livre Ier: Protection des personnes en matière de santé. Titre II: recherche biomédicales. Chapitre II: Information de la personne qui se prête à une recherche biomédicale et recueil de son consentement. Article L1122-2 (point II).
12. Federal Republic of Germany. Medicinal Products Act (Arzneimittelgesetz -Amg). Section 41. Special conditions for the clinical trial.Point 3(2).
13. Ireland (1987) Control of Clinical Trials Act, Section 9:7-b.
14. Ireland. The Medicines for Human Use (Clinical Trials) Regulations 2004 Statutory Instrument 2004 No.1031 Schedule 1 Regulation 2(1). Conditions and principles of good clinical practice and for the protection of clinical trial subjects. Part 5. Conditions and principles which apply in relation to an incapacitated adult.
15. Italy. Decreto Legislativo 24 giugno 2003, n. 211. Attuazione della direttiva 2001/20/CE relativa all'applicazione della buona pratica clinica nell'esecuzione delle sperimentazioni cliniche di medicinali per uso clinico. Gazzetta Ufficiale n. 184 del 9 agosto 2003 - Supplemento Ordinario n. 130. Art. 5(a).
16. Italy. Legge 9 gennaio 2004, n. 6. Introduzione nel libro primo, titolo XII del codice civile del capo I, relativo all'istituzione dell'amministrazione di sostegno e modifica degli articoli 338, 414 417, 418, 424, 426, 427 e 429 del codice civile in materia di interdizioni e di inabitazione, nonché relative norme di attuazione, di coordinamento e finali. Gazzetta Ufficiale della Repubblica Italiana - Serie generale. 19 Gennaio 2004, n. 14.
17. Netherlands. The Medical Research Involving Human Subjects Act. International Publication Series Health, Welfare and Sport nr. 2. The Hague, Netherlands 2006 March 1. Section 6 (c).
18. Spain. Real Decreto 223/2004de 6 de febrero, por el que se regulan los ensayos clínicos con medicamentos. Art.7:3(b,d).
19. UK. Medicines for Human Use (clinical Trials) Regulation 2004. Schedule 1, Part 1(2).
20. UK. Mental Capacity Act 2005. Section 32(4).
21. Germany.Third act on the amendment of the laws governing nursing care. 2009 July 29. Federal Law Gazette (Bundesgesetzblatt) 2009 Part I No 48, Bonn 2009 July 31.
22. Serrao E (2008) Questionario sull'amministrazione di sostegno. 2008 February 28. Available: http://www.personaedanno.it/cms/data/articoli/009779.aspx?catalog=2 Accessed 2010 March 3.
23. Izzicupo F, Vanacore N, Galeotti F, Menniti Ippolito F, Petrini C (2008) Parametri per la valutazione della capacità di esprimere il consenso al trattamento e strumenti per la loro misurazione. Rapporti Istisan 08/3: 14-22.
24. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of Illness in the Aged. The Index of Adl: A Standardized Measure of Biological and Psychosocial Function. JAMA 185: 914-919.
25. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: 179-186.
26. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572.
27. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
28. American Psychiatric Association: DSM-IV: Diagnostic and Statistical Manual on Mental Disorders. ed 4th, Washington, DC, American Psychiatric Association, 1994.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
30. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, et al. (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872.
31. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
32. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, et al. (1993) Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
33. Barbieri MP (2008) Caregiver-amministratore di sostegno: riconoscimento di un ruolo, sostegno all'opera di cura dei pazienti affetti da demenza. 2 Convegno Il contributo delle Unità di Valutazione Alzheimer (UVA) nell'assistenza dei pazienti con demenza. Istisan Congressi 08/C06; 22. Available: http://www.iss.it/binary/publ/cont/0393-5620_2008_I_08_C6.1221719443.pdf Accessed 2010 March 3.
34. Progetto di monitoraggio della somministrazione di memantina a pazienti con malattia di Alzheimer (AD). Regione Lombardia 2005; D.G.R.:VII/20954.
35. Clerici F, Vanacore N, Elia A, Spila-Alegiani S, Pomati S, et al. (2009) Memantine in moderately-severe-to-severe Alzheimer's disease: a postmarketing surveillance study. Drugs Aging 26: 321-332.
36. National Research Ethics Service (2007) Research involving adults unable to consent for themselves. London, UK. Available: www.nres.npsa.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=321 Accessed 2010 March 3.
37. Caulfield T (2005) Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment. Health Law Rev 13: 58-61.
38. Campbell EG, Weissman JS, Vogeli C, Clarridge BR, Abraham M, et al. (2006) Financial relationships between institutional review board members and industry. N Engl J Med 355: 2321-2329.
39. Kim SY, Kim HM, Langa KM, Karlawish JH, Knopman DS, et al. (2009) Surrogate consent for dementia research: a national survey of older Americans. Neurology 72: 149-155.
40. Kim SY, Kim HM, McCallum C, Tariot PN (2005) What do people at risk for Alzheimer disease think about surrogate consent for research? Neurology 65: 1395-1401.
41. Coppolino M, Ackerson L (2001) Do surrogate decision makers provide accurate consent for intensive care research? Chest 119: 603-612.
42. Sachs GA, Stocking CB, Stern R, Cox DM, Hougham G, et al. (1994) Ethical aspects of dementia research: informed consent and proxy consent. Clin Res 42: 403-412.
43. Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, et al. (2006) Speaking of research advance directives: planning for future research participation. Neurology 66: 1361-1366.